Vivos Therapeutics's total assets for Q1 2025 were $11.28M, a decrease of -26.18% from the previous quarter. VVOS total liabilities were $6.88M for the fiscal quarter, a -6.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.